Testing for Lung Cancer Genes - Consults Blog - NYTimes.com
Links shared publicly online about this topic.
- 1,011total visits
Testing for Lung Cancer Genes - Consults Blog - NYTimes.com
View full resource at consults.blogs.nytimes.com
Tags: Cancer, Lung Cancer, Lung, Genes, Cleveland Clinic
Most Recently Shared on July 19, 2010 at 3:06 pm By:
Testing for Lung Cancer Genes: Should you be tested for lung cancer genes? Dr. Derek Raghavan of the Cleveland Cli... http://bit.ly/d622ti
Study assesses link between antifolate medications, KRAS mutations and amplification
news-medical.net — “Testing patients with non-small cell lung cancer for both mutations and amplifications of the KRAS gene prior to therapy may help to predict response to treatment with antifolates, according to the updated results of a preclinical study presented at the AACR Annual Meeting 2012, held here March 31 - April 4.” View full resource at news-medical.net
Most Recently Shared on April 5, 2012 at 11:29 am By:
Lung Cancer News: Study assesses link between antifolate medications, KRAS mutations and amplification: Testing ... http://t.co/pTIigUcV
GRACE :: Lung Cancer» Blog Archive » Lucanix: A Vaccine Being Tested as a “Maintenance” Strategy in Advanced NSCLC
cancergrace.org — “GRACE :: Lung Cancer» Blog Archive » Lucanix: A Vaccine Being Tested as a “Maintenance” Strategy in Advanced NSCLC” View full resource at cancergrace.org
Most Recently Shared on January 31, 2012 at 12:56 am By:
H. Jack West, MD Internist, Health Executive, Oncologist, Physician, and Doctor
Accruing slowly, I think. RT @MaverickNY: @celltherapy @JackWestMD did nice post on Lucanix http://t.co/zq5t3Vod but not heard much since
Gene test may aid early-stage lung cancer patients
sfgate.com — “In a finding that could improve the survival odds for early-stage lung cancer patients, UCSF researchers have determined a new molecular test can predict more accurately than current diagnostic methods which tumors are...” View full resource at sfgate.com
Most Recently Shared on January 27, 2012 at 3:00 am By:
Breakthrough based on UCSF research could aid lung cancer patients http://t.co/2iHxoFdO
Ventana to Collaborate with Pfizer, CST on Lung Cancer Companion Diagnostic | IVD Technology
ivdtechnology.com — “Ventana Medical Systems Inc., a member of the Roche Group, has entered into a collaboration agreement with Pfizer Inc. and a license agreement with Cell Signaling Technology (CST) to develop the first fully automated and standardized immunohistochemistry (IHC) companion diagnostic test for ALK gene rearrangements.” View full resource at ivdtechnology.com
Most Recently Shared on January 10, 2012 at 7:04 pm By:
IVD Technology Health Magazine
Ventana to Collaborate with Pfizer, CST on Lung Cancer Companion Diagnostic http://t.co/KffSJglg
What Parents Tell Their Kids About Breast-Cancer Gene Test Results - Health Blog - WSJ
blogs.wsj.com — “Most kids took the news pretty well, at least according to their parents.” View full resource at blogs.wsj.com
Most Recently Shared on January 10, 2012 at 5:46 pm By:
Dr. Karen Horton Doctor, Surgeon, Plastic Surgeon, and Physician
http://t.co/q5TUz8tE What Parents Tell Their Kids About Breast Cancer Gene Test Results - BRCA gene-positive: to know or not?
New device uses gold nanoparticles to test for lung cancer — Colorado Cancer Blogs
coloradocancerblogs.org — “New device uses gold nanoparticles to test for lung cancer — Colorado Cancer Blogs” View full resource at coloradocancerblogs.org
Most Recently Shared on November 16, 2011 at 10:17 pm By:
New device uses gold nanoparticles to test for #lungcancer: http://t.co/cW6wTi4o #cancerresearch
Gene test helps tailored treatment for cancer patients - Yahoo! News
news.yahoo.com — “From Yahoo! News: Doctors on Wednesday said they had used a wide-ranging genetic test for mutations in cancer cells to help finetune treatment for patients with lung tumours.” View full resource at news.yahoo.com
Most Recently Shared on November 9, 2011 at 8:27 am By:
Raymond DuBois Physician, Doctor, Internist, Gastroenterologist, and Health Executive
Gene test helps tailored treatment for cancer patients - http://t.co/MIt63EX3 via @YahooNews
Oncimmune® (USA) LLC Recognizes Lung Cancer Awareness Month; Featuring 30 Individual Lung Cancer Stories - Yahoo! News
news.yahoo.com — “Read 'Oncimmune® (USA) LLC Recognizes Lung Cancer Awareness Month; Featuring 30 Individual Lung Cancer Stories' on Yahoo! News. Oncimmune (USA) LLC recognizes Lung Cancer Awareness Month through a unique public awareness campaign. Oncimmune will feature 30 lung cancer stories from survivors and loved ones impacted by lung cancer on the HelloHaveYouHeard.com blog.De Soto, KS (PRWEB) November 07, 2011 Oncimmune (USA) LLC, maker of EarlyCDT®-Lung, a simple blood test that aids physicians in the ear” View full resource at news.yahoo.com
Most Recently Shared on November 7, 2011 at 8:29 am By:
Oncimmune® (USA) LLC Recognizes Lung Cancer Awareness Month; Featuring 30 Individual Lung Cancer Stories: Oncimm... http://t.co/VBxpZlx0
ALK gene discovered by St. Jude scientists associated with FDA approved adult cancer drug
news-medical.net — “A drug recently approved by the U.S. Food and Drug Administration for treatment of an adult cancer targets a malfunctioning gene discovered more than a decade earlier at St. Jude Children's Research Hospital. The story highlights how scientific findings from St. Jude can be translated into therapies and tests that in addition to helping children, also help adults.” View full resource at news-medical.net
Most Recently Shared on September 30, 2011 at 1:46 pm By:
Lung Cancer News: ALK gene discovered by St. Jude scientists associated with FDA approved adult cancer drug: A d... http://t.co/nav6CsKf
Xalkori Approved To Treat Deadly Lung Cancer
huffingtonpost.com — “TRENTON, N.J. — Pfizer Inc.'s just-approved drug Xalkori, the first new medicine in more than six years for deadly lung cancer, proves the value of precisely targeting rare diseases linked to gene variants, cancer specialists and Pfizer executives said Tuesday. The drug was approved Friday in the U.S. along with a companion diagnostic test for just a small subset of lung cancer patients.” View full resource at huffingtonpost.com
Most Recently Shared on September 1, 2011 at 7:06 pm By:
Xalkori Approved To Treat Deadly Lung Cancer: TRENTON, N.J. — Pfizer Inc.'s just-approved drug Xalkori, the fir... http://t.co/kGWjJU9
Tarceva's new European OK points up Roche's targeted goals - FiercePharma
fiercepharma.com — “Roche's Tarceva has nabbed European approval as a first-line treatment for advanced lung cancer. It's an OK limited to non-small cell lung cancer that tests positive for a mutation in the EGFR gene. Read more...” View full resource at fiercepharma.com
Most Recently Shared on September 1, 2011 at 4:52 pm By:
Tarceva's new European OK points up Roche's targeted goals. http://t.co/1ETsXw1
Lung Cancer Pill Holds Promise For Those Who Pass Test : Shots - Health Blog : NPR
npr.org — “Only people with lung cancer that tests positive for a particular genetic variation are candidates for treatment with Pfizer's twice-a-day cancer pill called Xalkori. Most of those who qualified in clinical tests saw dramatic shrinkage of their tumors.” View full resource at npr.org
Most Recently Shared on September 1, 2011 at 12:09 am By:
Lung Cancer Pill Holds Promise For Those Who Pass Test : NPR http://t.co/tHS0iMV
Abbott Introduces Genetic Test for Lung Cancer | IVD Technology
ivdtechnology.com — “Abbott announced the availability of a new molecular test in the European Union and New Zealand designed to identify the presence of gene rearrangements associated with a specific form of non-small-cell lung cancer (NSCLC). These rearrangements in a gene known as ALK (anaplastic lymphoma kinase) have been implicated in the formation of cancerous tumors in patients with NSCLC.” View full resource at ivdtechnology.com
Most Recently Shared on August 31, 2011 at 4:22 pm By:
IVD Technology Health Magazine
Abbott Introduces Genetic Test for Lung Cancer http://t.co/6zKCyih
Lung Cancer Pill Holds Promise For Those Who Pass Test : Shots - Health Blog : NPR
npr.org — “Only people with lung cancer that tests positive for a particular genetic variation are candidates for treatment with Pfizer's twice-a-day cancer pill called Xalkori. Most of those who qualified in clinical tests saw dramatic shrinkage of their tumors.” View full resource at npr.org
Most Recently Shared on August 30, 2011 at 3:28 pm By:
krupali tejura, m.d. Oncologist, Radiation Oncologist, Physician, and Doctor
Lung #Cancer Pill Holds Promise For Those Who Pass Test-More at http://n.pr/qPVje7
Ahead of the Bell: Analyst sees Pfizer drug growth - Yahoo! News
news.yahoo.com — “Read 'Ahead of the Bell: Analyst sees Pfizer drug growth' on Yahoo! News. Pfizer Inc.'s newly approved lung cancer treatment Xalkori could bring in as much as $1 billion in sales by 2015, but its acceptance depends heavily on a new Abbott Laboratories gene test, according to a Citi analyst.” View full resource at news.yahoo.com
Most Recently Shared on August 29, 2011 at 6:35 pm By:
Ahead of the Bell: Analyst sees Pfizer drug growth: Pfizer Inc.'s newly approved lung cancer treatment Xalkori ... http://t.co/FOvejC2
Advertisement
